Products
With an outstanding track record and unwavering commitment to excellence, they consistently deliver the highest quality products to various industries.
Ritonavir (CAS 155213-67-5)
Ritonavir (CAS 155213-67-5) is a medication that belongs to the class of antiretroviral drugs known as protease inhibitors. It is primarily used in the treatment of HIV (human immunodeficiency virus) infection.
Products Description
Ritonavir
Product Name: | Ritonavir |
CAS No.: | 155213-67-5 |
Molecular formula: | C37H48N6O5S2 |
Molecular weight: | 720.94 |
Purity: | ≥99% |
Description: | A selective HIV protease inhibitor. It is a COVID19-related research product. |
Product Description
Ritonavir (CAS 155213-67-5) is a medication that belongs to the class of antiretroviral drugs known as protease inhibitors. It is primarily used in the treatment of HIV (human immunodeficiency virus) infection. Ritonavir is often prescribed as part of combination therapy, which involves using multiple antiretroviral drugs simultaneously to effectively manage HIV.
Key points about ritonavir include:
- Mechanism of Action: Ritonavir works by inhibiting the activity of the HIV protease enzyme. This enzyme plays a crucial role in the replication of the virus by cleaving viral polyproteins into individual functional proteins. By inhibiting the protease enzyme, ritonavir prevents the production of mature and infectious viral particles, thereby suppressing viral replication.
- Indications: Ritonavir is primarily used in the treatment of HIV-1 infection in combination with other antiretroviral drugs. It helps reduce viral load, slow down disease progression, and improve the immune system’s function.
- Boosting Agent: Ritonavir is also commonly used as a “pharmacokinetic enhancer” or a “booster” for other protease inhibitors. When used in lower doses alongside certain protease inhibitors, ritonavir inhibits enzymes responsible for breaking down these other drugs, leading to increased drug levels in the blood. This boosting effect allows for improved efficacy and reduced dosing frequency of the co-administered protease inhibitor.
- Dosage and Administration: Ritonavir is available in oral capsule or liquid form. The dosage and administration regimen depend on factors such as the patient’s weight, other medications being taken, and the specific treatment plan determined by a healthcare provider.
- Side Effects: Common side effects of ritonavir may include gastrointestinal symptoms (such as nausea, vomiting, and diarrhea), elevated liver enzymes, lipid abnormalities, changes in body fat distribution, and interactions with other medications. Regular monitoring of liver function and lipid levels is often recommended during ritonavir therapy.
- Drug Interactions: Ritonavir has the potential to interact with a wide range of medications due to its inhibition of drug-metabolizing enzymes. It is important to inform healthcare providers about all current medications to avoid potential interactions.
Ritonavir should be used under the supervision of a healthcare professional experienced in the management of HIV infection. It is crucial to follow the prescribed dosage and regimen, as well as maintain regular medical monitoring to assess treatment effectiveness and manage any potential side effects or drug interactions.